WASHINGTON, April 16 -- Harvard Bioscience Inc., Holliston, Mass., files Form 8-K (current report) with Securities and Exchange Commission on April 15.
State or other jurisdiction of incorporation: Delaware
Regulation FD Disclosure.
On April 15, 2011, Harvard Bioscience, Inc. (the "Company") , in connection with mailing the Notice of Internet Availability of Proxy Materials to shareholders for the 2011 Annual Meeting of Stockholders, made its Proxy Statement and 2010 Annual Report (the "Annual Report") available online at www.proxyvote.com. The 2010 Annual Report is also available on the Company's website at www.harvardbioscience.com. Excerpts from the Annual Report are furnished hereto as Exhibit 99.1 and incorporated by reference into this Item 7.01 in satisfaction of the public disclosure requirements of Regulation FD.
The information set forth in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number - Title
99.1 - Excerpts from Annual Report
More information can be viewed at: http://www.sec.gov/Archives/edgar/data/1123494/000119312511099206/d8k.htm For any query with respect to this article or any other content requirement, please contact Editor at htsyndication@hindustantimes.com
http://www.sec.gov/Archives/edgar/data/1123494/000119312511099206/d8k.htm
No comments:
Post a Comment